Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Frederick J, Derosier"'
Autor:
Amit, Bar-Or, Richard A, Grove, Jerry M, Tolson, Frederick J, Derosier, Monica C, Lopez, Sarah T, Kavanagh, Aaron E, Miller
Publikováno v:
Neurology. 92(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b75d32f23c4af191b7acd09819dfa50e
https://pubmed.ncbi.nlm.nih.gov/30858244
https://pubmed.ncbi.nlm.nih.gov/30858244
Autor:
Jason D, Ferrone, Gourab, Bhattacharjee, Alexey S, Revenko, Thomas A, Zanardi, Marshelle S, Warren, Frederick J, Derosier, Nicholas J, Viney, Nguyen C, Pham, Gwendolyn E, Kaeser, Brenda F, Baker, Eugene, Schneider, Steven G, Hughes, Brett P, Monia, A Robert, MacLeod
Publikováno v:
Nucleic Acid Therapeutics
Kallikrein is the key contact system mediator responsible for the conversion of high-molecular-weight kininogen into the inflammatory vasodilator peptide bradykinin, a process regulated by C1-esterase inhibitor (C1-INH). In hereditary angioedema (HAE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b54043aab3722f9df30ce8645b4f7232
https://pubmed.ncbi.nlm.nih.gov/30817230
https://pubmed.ncbi.nlm.nih.gov/30817230
Autor:
Susan A. McDonald, Michael P. Diamond, Jeanne E. Ballard, Vincent T. Martin, Shelly E. Lener, Alok Krishen, Frederick J. Derosier, Lisa K. Mannix
Publikováno v:
Journal of Women's Health. 23:389-396
Dysmenorrhea and menstrual migraine may share a common pathogenic pathway. Both appear to be mediated, in part, by an excess of prostaglandin production that occurs during menstruation.Data were pooled from two replicate randomized controlled trials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcaac34808090a36f1ef5ab347a6fa33
https://doi.org/10.1089/jwh.2013.4577
https://doi.org/10.1089/jwh.2013.4577
Autor:
Jelena Drulovic, Massimo Filippi, Richard Grove, Steve Shackelford, Per Soelberg Sørensen, Steen Lisby, Frederick J. Derosier, Eva Havrdova
Publikováno v:
Neurology. 82:573-581
We present the first study to explore safety and efficacy of the human CD20 monoclonal antibody ofatumumab in relapsing-remitting multiple sclerosis (RRMS).In this randomized, double-blind, placebo-controlled study, patients received 2 ofatumumab inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f033eba1fe3d6f59f14f96625386db8f
https://doi.org/10.1212/wnl.0000000000000125
https://doi.org/10.1212/wnl.0000000000000125
Autor:
Jane Saiers, Frederick J. Derosier, Stephen D. Silberstein, Jonathan White, Susan A. McDonald, Richard B. Lipton, Sheena K. Aurora, Jerome Goldstein, Shelly E. Lener, Michael C Runken
Publikováno v:
Cephalalgia. 34:268-279
Objective Probable migraine is a common, disabling migraine subtype fulfilling all but one of the diagnostic criteria for migraine. This study was conducted to evaluate the efficacy and tolerability of sumatriptan/naproxen sodium for the acute treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee5f169ad1c2e399b981b77fe88577e
https://doi.org/10.1177/0333102413508242
https://doi.org/10.1177/0333102413508242
Autor:
Frederick J. Derosier, Fred D. Sheftell, Gary E. Ruoff, Alok Krishen, Margaret Asby Peykamian, Stephen D. Silberstein, Roger Cady
Publikováno v:
Headache: The Journal of Head and Face Pain. 52:530-543
Objectives.— The primary objective was to compare the efficacy of a sumatriptan and naproxen combination medication (SumaRT/Nap—85 mg sumatriptan and 500 mg naproxen sodium), a butalbital-containing combination medication (BCM—50 mg butalbital,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01ea7d6062476a242f99dd2717146627
https://doi.org/10.1111/j.1526-4610.2011.02039.x
https://doi.org/10.1111/j.1526-4610.2011.02039.x
Publikováno v:
The Journal of Clinical Hypertension. 13:910-916
Anti-inflammatory and pain therapies have been associated with blood pressure (BP) destabilization. Hence, the effects on BP of sumatriptan/naproxen sodium in fixed-dose combination, sumatriptan 85 mg, and naproxen sodium 500 mg administered intermit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3372e2a2a322ce6f9dc9697c86ad92b8
https://doi.org/10.1111/j.1751-7176.2011.00554.x
https://doi.org/10.1111/j.1751-7176.2011.00554.x
Autor:
Michael P. Diamond, Susan A. McDonald, Jeanne E. Ballard, Roger Cady, Frederick J. Derosier, Deborah P. Dorner, Merle L. Diamond, Michelle E. Lener, Jonathan White, M. Chris Runken
Publikováno v:
Headache: The Journal of Head and Face Pain. 51:664-673
(Headache 2011;51:664-673) Objective.— To evaluate the impact of a sumatriptan/naproxen sodium combination tablet on patient satisfaction, productivity, and functional disability in menstrual migraine treated during the mild pain phase of a single
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58c9f8bb8fd1f475b2ae832f4d5fd5bc
https://doi.org/10.1111/j.1526-4610.2011.01894.x
https://doi.org/10.1111/j.1526-4610.2011.01894.x
Autor:
Per Soelberg Sørensen, Eric W. Lewis, Aaron E. Miller, Daren Austin, Sarah T. Kavanagh, Richard A. Grove, Susan A. VanMeter, Jerry M. Tolson, Monica C. Lopez, Amit Bar-Or, Frederick J. Derosier
Publikováno v:
Neurology
Bar-Or, A, Grove, R A, Austin, D J, Tolson, J M, VanMeter, S A, Lewis, E W, Derosier, F J, Lopez, M C, Kavanagh, S T, Miller, A E & Sorensen, P S 2018, ' Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis : The MIRROR study ', Neurology, vol. 90, no. 20, pp. e1805-e1814 . https://doi.org/10.1212/WNL.0000000000005516
Bar-Or, A, Grove, R A, Austin, D J, Tolson, J M, VanMeter, S A, Lewis, E W, Derosier, F J, Lopez, M C, Kavanagh, S T, Miller, A E & Sorensen, P S 2018, ' Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis : The MIRROR study ', Neurology, vol. 90, no. 20, pp. e1805-e1814 . https://doi.org/10.1212/WNL.0000000000005516
ObjectiveTo assess dose-response effects of the anti-CD20 monoclonal antibody ofatumumab on efficacy and safety outcomes in a phase 2b double-blind study of relapsing forms of multiple sclerosis (RMS).MethodsPatients (n = 232) were randomized to ofat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::103a62e18d127fae1d8608472ca87182
https://doi.org/10.1212/wnl.0000000000005929
https://doi.org/10.1212/wnl.0000000000005929
Autor:
Ninan T. Mathew, Shelly E. Lener, Gretchen E. Tietjen, Frederick J. Derosier, Stuart R. Stark, Deo Bukenya, Stephen H. Landy, Jonathan White
Publikováno v:
Headache: The Journal of Head and Face Pain. 49:971-982
Objective.— To evaluate efficacy and tolerability of a single, fixed-dose tablet of sumatriptan 85 mg/naproxen sodium 500 mg (sumatriptan/naproxen sodium) vs placebo in migraineurs who had discontinued treatment with a short-acting triptan because
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8dc1f5511eb519e7afdf045a7e189fa
https://doi.org/10.1111/j.1526-4610.2009.01458.x
https://doi.org/10.1111/j.1526-4610.2009.01458.x